BARCELONA, Spain--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, will present new findings that showcase the benefits of its glucose biosensing technology for ...

In December, online rumors hinted at the fact that Dexcom may be planning to sunset its G6 CGM sensor model. The company has now started to notify patients of the discontinuation plan. The company ...

Feb 12 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab beat Wall Street estimates for fourth-quarter results on Thursday, driven by robust demand for its continuous glucose monitoring ...

Apple Watch now supports glucose monitoring via CGMs like Dexcom G7, while Apple continues long-term work on non-invasive blood sugar tracking. Apple Watch has taken a significant step forward with ...

In his inaugural J.P. Morgan Healthcare Conference speech, newly minted Dexcom CEO Jake Leach looked to ease concerns over last year's supply shortage of the company's leading diabetes product. Leach ...

Mr. Leach begins his inaugural year as CEO with speaking engagements at CES 2026 and the 44 th annual J.P. Morgan Healthcare Conference A completely reimagined Stelo app experience will launch this ...

Supermodel Bambi Northwood-Blyth wears a Dexcom glucose monitor. So does your next-door neighbor with Type 2 diabetes and your fit-fluencer friend. Jake Leach, who took over as Dexcom CEO today, wants ...

ABSTRACT: Microfluidic wearables move microliter biofluids across soft, low-impedance interfaces and into stable transducers on skin, enabling time-stamped chemistry without pumps. In this review ...

The Beta Bionics iLet and Dexcom G7 15 Day CGM. [Images courtesy of the companies] Beta Bionics (Nasdaq:BBNX) took to social media to announce the integration of its iLet Bionic Pancreas with Dexcom’s ...